Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial.
Öhnstedt E, Vågesjö E, Fasth A, Lofton Tomenius H, Dahg P, Jönsson S, Tyagi N, Åström M, Myktybekova Z, Ringstad L, Jorvid M, Frank P, Hedén P, Roos S, Phillipson M.
Öhnstedt E, et al. Among authors: roos s.
EClinicalMedicine. 2023 May 25;60:102014. doi: 10.1016/j.eclinm.2023.102014. eCollection 2023 Jun.
EClinicalMedicine. 2023.
PMID: 37251631
Free PMC article.